BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 15698711)

  • 1. Emerging epidemic of metallo-beta-lactamase-mediated resistances.
    Jones RN; Biedenbach DJ; Sader HS; Fritsche TR; Toleman MA; Walsh TR
    Diagn Microbiol Infect Dis; 2005 Feb; 51(2):77-84. PubMed ID: 15698711
    [No Abstract]   [Full Text] [Related]  

  • 2. New β-lactam antibiotics and β-lactamase inhibitors.
    Bush K; Macielag MJ
    Expert Opin Ther Pat; 2010 Oct; 20(10):1277-93. PubMed ID: 20839927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and in vitro antibacterial properties of 2-(3-bromo-5-isoxazolylideneamino-oxy)acetamido-beta-lactam derivatives.
    Sala A; Chiarino D; Napoletano M; Albini E; Carenzi A
    Farmaco; 1991; 46(7-8):887-97. PubMed ID: 1793473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The new beta-lactamases.
    Jacoby GA; Munoz-Price LS
    N Engl J Med; 2005 Jan; 352(4):380-91. PubMed ID: 15673804
    [No Abstract]   [Full Text] [Related]  

  • 5. The emergence and implications of metallo-beta-lactamases in Gram-negative bacteria.
    Walsh TR
    Clin Microbiol Infect; 2005 Nov; 11 Suppl 6():2-9. PubMed ID: 16209700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired metallo-beta-lactamases: an increasing clinical threat.
    Rossolini GM
    Clin Infect Dis; 2005 Dec; 41(11):1557-8. PubMed ID: 16267726
    [No Abstract]   [Full Text] [Related]  

  • 7. High prevalence of co-expression of newer beta-lactamases (ESBLs, Amp-C-beta-lactamases, and metallo-beta-lactamases) in gram-negative bacilli.
    Chatterjee SS; Karmacharya R; Madhup SK; Gautam V; Das A; Ray P
    Indian J Med Microbiol; 2010; 28(3):267-8. PubMed ID: 20644325
    [No Abstract]   [Full Text] [Related]  

  • 8. Providencia stuartii with VIM-1 metallo-beta-lactamase.
    Miriagou V; Tzouvelekis LS; Flevari K; Tsakiri M; Douzinas EE
    J Antimicrob Chemother; 2007 Jul; 60(1):183-4. PubMed ID: 17517828
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro activities of ertapenem against drug-resistant Streptococcus pneumoniae and other respiratory pathogens from 12 Asian countries.
    Song JH; Ko KS; Lee MY; Park S; Baek JY; Lee JY; Heo ST; Kwon KT; Ryu SY; Oh WS; Peck KR; Lee NY
    Diagn Microbiol Infect Dis; 2006 Dec; 56(4):445-50. PubMed ID: 16949783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parenteral carbapenems.
    Shah PM
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():175-80. PubMed ID: 18154543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved performance of the modified Hodge test with MacConkey agar for screening carbapenemase-producing Gram-negative bacilli.
    Lee K; Kim CK; Yong D; Jeong SH; Yum JH; Seo YH; Docquier JD; Chong Y
    J Microbiol Methods; 2010 Nov; 83(2):149-52. PubMed ID: 20801167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in carbapenemase-producing Escherichia coli and Klebsiella spp. from Europe and the Americas: report from the SENTRY antimicrobial surveillance programme (2007-09).
    Castanheira M; Mendes RE; Woosley LN; Jones RN
    J Antimicrob Chemother; 2011 Jun; 66(6):1409-11. PubMed ID: 21421581
    [No Abstract]   [Full Text] [Related]  

  • 13. Defining an extended-spectrum beta-lactamase.
    Livermore DM
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():3-10. PubMed ID: 18154524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The threat of antibiotic resistance in Gram-negative pathogenic bacteria: beta-lactams in peril!
    Thomson JM; Bonomo RA
    Curr Opin Microbiol; 2005 Oct; 8(5):518-24. PubMed ID: 16126451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of disk preparation on detection of metallo-beta-lactamase-producing isolates by the combined disk assay.
    Andrade SS; Picão RC; Campana EH; Nicoletti AG; Pignatari AC; Gales AC
    J Clin Microbiol; 2007 Jun; 45(6):2058-60. PubMed ID: 17409202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended-spectrum beta-lactamases: a brief clinical update.
    Malloy AM; Campos JM
    Pediatr Infect Dis J; 2011 Dec; 30(12):1092-3. PubMed ID: 22105419
    [No Abstract]   [Full Text] [Related]  

  • 17. Increasing extended-spectrum beta-lactamase production and quinolone resistance among Gram-negative bacilli causing intra-abdominal infections in the Asia/Pacific region: data from the Smart Study 2002-2006.
    Ko WC; Hsueh PR
    J Infect; 2009 Aug; 59(2):95-103. PubMed ID: 19564044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metallo-β-lactamases: a last frontier for β-lactams?
    Cornaglia G; Giamarellou H; Rossolini GM
    Lancet Infect Dis; 2011 May; 11(5):381-93. PubMed ID: 21530894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New aspects on resistance to beta-lactam antibiotics].
    Bakken JS; Sanders CC
    Nord Med; 1987; 102(12):354-6. PubMed ID: 3697059
    [No Abstract]   [Full Text] [Related]  

  • 20. [Broad-spectrum beta-lactamases in Gram-negative bacteria].
    Sundsfjord A; Simonsen GS; Haldorsen B; Lundblad EW; Samuelsen O
    Tidsskr Nor Laegeforen; 2008 Dec; 128(23):2741-5. PubMed ID: 19079424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.